• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将胰岛素靶向肝脏可以纠正由于外周胰岛素输送引起的葡萄糖代谢缺陷。

Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.

机构信息

Vanderbilt University School of Medicine, Department of Molecular Physiology and Biophysics, Nashville, Tennessee, USA.

Vanderbilt University Medical Center, Division of Surgical Research, Nashville, Tennessee, USA.

出版信息

JCI Insight. 2019 Feb 26;5(7):126974. doi: 10.1172/jci.insight.126974.

DOI:10.1172/jci.insight.126974
PMID:30830873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6483654/
Abstract

Peripheral hyperinsulinemia resulting from subcutaneous insulin injection is associated with metabolic defects which include abnormal glucose metabolism. The first aim of this study was to quantify the impairments in liver and muscle glucose metabolism that occur when insulin is delivered via a peripheral vein compared to when it is given through its endogenous secretory route (the hepatic portal vein) in overnight fasted conscious dogs. The second aim was to determine if peripheral delivery of a hepato-preferential insulin analog could restore the physiologic response to insulin that occurs under meal feeding conditions. This study is the first to show that hepatic glucose uptake correlates with insulin's direct effects on the liver under hyperinsulinemic-hyperglycemic conditions. In addition, glucose uptake was equally divided between the liver and muscle when insulin was infused into the portal vein, but when it was delivered into a peripheral vein the percentage of glucose taken up by muscle was 4-times greater than that going to the liver, with liver glucose uptake being less than half of normal. These defects could not be corrected by adjusting the dose of peripheral insulin. On the other hand, hepatic and non-hepatic glucose metabolism could be fully normalized by a hepato-preferential insulin analog.

摘要

皮下注射胰岛素导致的外周高胰岛素血症与代谢缺陷有关,包括葡萄糖代谢异常。本研究的第一个目的是定量比较胰岛素经外周静脉给药与经内源性分泌途径(肝门静脉)给药时,在夜间禁食清醒犬中肝脏和肌肉葡萄糖代谢的损伤。第二个目的是确定肝靶向胰岛素类似物经外周给药是否可以恢复在进食条件下发生的胰岛素生理反应。这项研究首次表明,在高胰岛素-高血糖状态下,肝脏葡萄糖摄取与胰岛素对肝脏的直接作用相关。此外,当胰岛素注入门静脉时,葡萄糖摄取在肝脏和肌肉之间均等分配,但当胰岛素注入外周静脉时,肌肉摄取的葡萄糖百分比是肝脏的 4 倍,而肝脏葡萄糖摄取量不到正常的一半。这些缺陷不能通过调整外周胰岛素剂量来纠正。另一方面,肝靶向胰岛素类似物可完全使肝和非肝葡萄糖代谢正常化。

相似文献

1
Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery.将胰岛素靶向肝脏可以纠正由于外周胰岛素输送引起的葡萄糖代谢缺陷。
JCI Insight. 2019 Feb 26;5(7):126974. doi: 10.1172/jci.insight.126974.
2
A negative arterial-portal venous glucose gradient decreases skeletal muscle glucose uptake.动脉-门静脉葡萄糖梯度为负会降低骨骼肌对葡萄糖的摄取。
Am J Physiol. 1998 Jul;275(1):E101-11. doi: 10.1152/ajpendo.1998.275.1.E101.
3
Profound Sensitivity of the Liver to the Direct Effect of Insulin Allows Peripheral Insulin Delivery to Normalize Hepatic but Not Muscle Glucose Uptake in the Healthy Dog.胰岛素对肝脏的直接作用极其敏感,这使得外周胰岛素的输送能够使健康犬的肝脏而非肌肉葡萄糖摄取正常化。
Diabetes. 2023 Feb 1;72(2):196-209. doi: 10.2337/db22-0471.
4
Hepatic and muscle insulin action during late pregnancy in the dog.犬妊娠晚期肝脏和肌肉的胰岛素作用
Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R447-52. doi: 10.1152/ajpregu.00385.2006. Epub 2006 Sep 14.
5
Morning Engagement of Hepatic Insulin Receptors Improves Afternoon Hepatic Glucose Disposal and Storage.早晨肝脏胰岛素受体的激活可改善下午肝脏的葡萄糖处置和储存。
bioRxiv. 2024 Sep 27:2024.09.25.614969. doi: 10.1101/2024.09.25.614969.
6
Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans.在人体中,肝糖生成受胰岛素的直接肝脏作用及肝外作用的双重调节。
Diabetes. 1996 Apr;45(4):454-62. doi: 10.2337/diab.45.4.454.
7
Portal glucose delivery stimulates muscle but not liver protein metabolism.门静脉葡萄糖输注刺激肌肉而非肝脏蛋白质代谢。
Am J Physiol Endocrinol Metab. 2012 Nov 15;303(10):E1202-11. doi: 10.1152/ajpendo.00140.2012. Epub 2012 Sep 25.
8
Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.门静脉内给予 exenatide 对清醒犬肝葡萄糖代谢的影响。
Am J Physiol Endocrinol Metab. 2013 Jul 1;305(1):E132-9. doi: 10.1152/ajpendo.00160.2013. Epub 2013 May 14.
9
A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog.选择性增加外周或门静脉胰岛素对清醒犬肝脏葡萄糖生成影响的比较。
Diabetes. 1996 Nov;45(11):1594-604. doi: 10.2337/diab.45.11.1594.
10
Fatty acids mediate the acute extrahepatic effects of insulin on hepatic glucose production in humans.脂肪酸介导胰岛素对人体肝脏葡萄糖生成的急性肝外效应。
Diabetes. 1997 Jul;46(7):1111-9. doi: 10.2337/diab.46.7.1111.

引用本文的文献

1
Hepatic Glucose Uptake During Euglycemic Hyperinsulinemia Associates With Glycemia During Oral Glucose Tolerance Test.正常血糖高胰岛素血症期间的肝脏葡萄糖摄取与口服葡萄糖耐量试验期间的血糖相关。
J Endocr Soc. 2025 Apr 2;9(5):bvaf054. doi: 10.1210/jendso/bvaf054. eCollection 2025 May.
2
Improved Afternoon Hepatic Glucose Disposal and Storage Requires Morning Engagement of Hepatic Insulin Receptors.改善午后肝脏葡萄糖处置与储存需要早晨肝脏胰岛素受体的参与。
Diabetes. 2025 Mar 1;74(3):270-281. doi: 10.2337/db24-0786.
3
Efficacy of Oral Nanoparticle-Encapsulated Insulin in Reducing Oxidative Stress and Enhancing Tissue Integrity in a Diabetic Rat Model.口服纳米颗粒包裹胰岛素在糖尿病大鼠模型中降低氧化应激和增强组织完整性的疗效。
Int J Nanomedicine. 2024 Oct 28;19:10961-10981. doi: 10.2147/IJN.S468756. eCollection 2024.
4
Morning Engagement of Hepatic Insulin Receptors Improves Afternoon Hepatic Glucose Disposal and Storage.早晨肝脏胰岛素受体的激活可改善下午肝脏的葡萄糖处置和储存。
bioRxiv. 2024 Sep 27:2024.09.25.614969. doi: 10.1101/2024.09.25.614969.
5
Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.进食混合宏量营养素餐后,血浆胰高血糖素水平升高与 2 型糖尿病患者和非糖尿病患者的胰岛素清除率降低有关。
Diabetologia. 2024 Nov;67(11):2555-2567. doi: 10.1007/s00125-024-06249-7. Epub 2024 Aug 13.
6
Oral peptide therapeutics for diabetes treatment: State-of-the-art and future perspectives.用于糖尿病治疗的口服肽疗法:现状与未来展望。
Acta Pharm Sin B. 2024 May;14(5):2006-2025. doi: 10.1016/j.apsb.2024.02.019. Epub 2024 Feb 28.
7
The Basis for Weekly Insulin Therapy: Evolving Evidence With Insulin Icodec and Insulin Efsitora Alfa.每周胰岛素治疗的基础:带有胰岛素 Icodec 和胰岛素 Efsitora Alfa 的不断发展的证据。
Endocr Rev. 2024 May 7;45(3):379-413. doi: 10.1210/endrev/bnad037.
8
Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies.胰岛素治疗糖尿病:创新治疗策略的叙述性综述
Diabetes Ther. 2023 Nov;14(11):1801-1831. doi: 10.1007/s13300-023-01468-4. Epub 2023 Sep 22.
9
Delivery of biologics: Topical administration.生物制剂的传递:局部给药。
Biomaterials. 2023 Nov;302:122312. doi: 10.1016/j.biomaterials.2023.122312. Epub 2023 Sep 4.
10
Insulin Tregopil: An Ultra-Fast Oral Recombinant Human Insulin Analog: Preclinical and Clinical Development in Diabetes Mellitus.胰岛素特充乐:一种超快速口服重组人胰岛素类似物:在糖尿病中的临床前和临床开发。
Drugs. 2023 Sep;83(13):1161-1178. doi: 10.1007/s40265-023-01925-1. Epub 2023 Aug 14.

本文引用的文献

1
Development of new basal insulin peglispro (LY2605541) ends in a disappointing result.新型基础胰岛素聚乙二醇化赖脯胰岛素(LY2605541)的研发以令人失望的结果告终。
Diabetol Int. 2016 Jan 29;7(1):16-17. doi: 10.1007/s13340-016-0255-1. eCollection 2016 Mar.
2
Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.胰岛素的直接肝脏作用解释了胰岛素分泌引起的葡萄糖生成抑制。
JCI Insight. 2017 Mar 23;2(6):e91863. doi: 10.1172/jci.insight.91863.
3
Finding the right route for insulin delivery - an overview of implantable pump therapy.寻找胰岛素给药的合适途径——植入式泵疗法概述
Expert Opin Drug Deliv. 2017 Sep;14(9):1103-1111. doi: 10.1080/17425247.2017.1267138. Epub 2016 Dec 7.
4
Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities.口服胰岛素治疗糖尿病:现状、挑战与机遇
J Pharm Pharmacol. 2016 Sep;68(9):1093-108. doi: 10.1111/jphp.12607. Epub 2016 Jun 30.
5
Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production.直接的肝细胞胰岛素信号传导是脂肪生成所必需的,但对抑制葡萄糖生成来说并非必需。
Cell Metab. 2016 Jun 14;23(6):1154-1166. doi: 10.1016/j.cmet.2016.04.022. Epub 2016 May 26.
6
Lessons From Peglispro: IMAGINE How to Improve Drug Development and Affordability.来自聚乙二醇化胰岛素原的经验教训:设想如何改善药物研发与可及性。
Diabetes Care. 2016 Apr;39(4):499-501. doi: 10.2337/dc15-2754.
7
Hepatic glycogen can regulate hypoglycemic counterregulation via a liver-brain axis.肝糖原可通过肝-脑轴调节低血糖反调节。
J Clin Invest. 2016 Jun 1;126(6):2236-48. doi: 10.1172/JCI79895. Epub 2016 May 3.
8
Too Much or Too Little? The Double Jeopardy of Subcutaneous Insulin Therapy in Diabetes.过多还是过少?糖尿病皮下胰岛素治疗的双重困境
Diabetes. 2015 Oct;64(10):3353-4. doi: 10.2337/dbi15-0003.
9
Insulin Delivery Into the Peripheral Circulation: A Key Contributor to Hypoglycemia in Type 1 Diabetes.胰岛素进入外周循环:1型糖尿病低血糖的关键因素。
Diabetes. 2015 Oct;64(10):3439-51. doi: 10.2337/db15-0071. Epub 2015 Jun 17.
10
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.肝脏胰岛素信号传导对于胰岛素在体内抑制葡萄糖生成并非必需。
Nat Commun. 2015 May 12;6:7078. doi: 10.1038/ncomms8078.